EBIT (Quarterly)

EBIT: Income before interest and taxes.

Pacira BioSciences, Inc. (PCRX) had EBIT of $6.36M for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$179.52M
Net Income	$5.43M
Cost of Goods Sold	$34.28M
Gross Profit	$145.24M
Operating Expenses	$173.15M
Operating Income	$6.36M
Non-Operating Income/Expense	$3.16M
Pre-Tax Income	$9.52M
Normalized Pre-Tax Income	$9.52M
Income after Taxes	$5.43M
Income from Continuous Operations	$5.43M
Consolidated Net Income/Loss	$5.43M
Normalized Income after Taxes	$5.43M
EBIT	$6.36M
EBITDA	$28.23M
Weighted-Average Shares Outstanding (Basic)	44.04M
Weighted-Average Shares Outstanding (Diluted)	44.46M
Earnings per Share (EPS) (Basic)	$0.12
Earnings per Share (EPS) (Diluted)	$0.12
Balance Sheet Financials
Current Assets	$562.75M
Property, Plant, and Equipment	$147.39M
Long-Term Assets	$734.83M
Total Assets	$1.30B
Current Liabilities	$107.08M
Long-Term Debt	$376.72M
Long-Term Liabilities	$463.29M
Total Liabilities	$570.36M
Common Equity	$727.21M
Tangible Shareholders Equity	$324.50M
Shareholders Equity	$727.21M
Common Shares Outstanding	42.97M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$108.31M
Cash Flow from Investing Activities	$80.15M
Cash Flow from Financial Activities	$-317.98M
Beginning Cash	$276.77M
End Cash	$147.59M
Increase/Decrease in Cash	$-129.19M
Stock-Based Compensation	$44.00M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	5.26
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.34
Debt to Equity Ratio	0.52
Gross Margin	80.91%
Operating Margin	3.54%
EBIT Margin	3.54%
EBITDA Margin	--
Pre-Tax Profit Margin	5.31%
Profit Margin	3.03%
Free Cash Flow	$93.19M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.14
Inventory Turnover	0.22
Receiveable Turnover	1.56
Days Sales in Receivables	57.79
Return on Equity	0.75%
Return on Tangible Equity	1.67%
Return on Assets	0.42%
Return on Investments	0.49%
Book Value Per Share	$16.93
Free Cash Flow per Share	$2.10
Operating Cash Flow per Share	$2.44

Data from Zacks Investment Research, Inc.